Screening for hypothalamic-pituitary-adrenal axis suppression in asthmatic children remains problematic: A cross-sectional study

BMJ Open

Volumn 3, Issue 8, 2013, Pages

  Zöllner, Ekkehard Werner ^a,b   Lombard, Carl J ^c   Galal, Ushma ^c   Hough, Stephen ^a   Irusen, Elvis M ^a   Weinberg, Eugene ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTODOXONE; HYDROCORTISONE; METYRAPONE; PRASTERONE SULFATE;

ADRENAL SUPPRESSION; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BODY HEIGHT; BODY WEIGHT; CHILD; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRESCHOOL CHILD; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STANDING; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE; VELOCITY;

EID: 84884554102     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-002935     Document Type: Article

References (30)

1. Zöllner EW, Lombard C, Galal U, et al. Hypothalamic-piuitary-adrenal axis suppression in asthmatic school children. Pediatrics 2012;130:e1512-19.
2. Zöllner EW. Hypothalamic-piuitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids: Part 1. Which test should be used? Pediatr Allergy Immunol 2007;18:401-9. (Pubitemid 47039145)
3. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4. (Pubitemid 34233764)
4. Hammond M, Gear J. Measuring community health. Workbook 1. Cape Town: Oxford University Press, 1986:299-334.
5. Zöllner EW, Lombard C, Galal U, et al. Hypothalamic-pituitary- adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test? Pediatr Allergy Immunol 2011;22:614-20.
6. Dorsey MJ, Cohen LE, Phipatanakul W, et al. Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulphate as a screening test. Ann Allergy Asthma Immunol 2006;97:182-6. (Pubitemid 44272583)
7. Kannisto S, Laatikainen A, Taivainen A, et al. Serum dehydroepiandrosterone sulfate as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. Eur J Endocrinol 2004;150:687-90. (Pubitemid 38786539)
8. Skoner DP, Meltzer EO, Milgrom H, et al. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma. J Asthma 2011;48:848-59.
9. Allen A, Schenkenberger I, Trivedi R, et al. Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma; randomised, double-blind, placebo-controlled study. Clin Respir J Published ahead of print: 12 Apr. 2013. doi:10.1111/crj.12026
10. Bleeker ER, Bateman ED, Busse WW, et al. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids. Ann Allergy Asthma Immunol 2012;109:353-8.
11. Aaron DC. Diagnostic implications of adrenal physiology and clinical epidemiology for evaluation of glucocorticoid excess and deficiency. In: De Groot LJ, Jameson J, eds. Endocrinology. Vol 3. Philadelphia: WB Saunders Company, 2001:1655-70.
12. Motala C, Green RJ, Manjra AI, et al. Guideline for the management of chronic asthma in children-2009 update. S Afr Med J 2009;99:898-912.
13. Forest MG. Adrenal function tests. In: Ranke MB, ed. Diagnostics of endocrine function in children and adolescents. Basel: Karger, 2003:372-426.
14. Staub JJ, Noelpp B, Girard J, et al. The short metyrapone test: comparison of the plasma ACTH response to metyrapone and insulin-induced hypoglycaemia. Clin Endocrinol 1979;10:595-601. (Pubitemid 10185575)
15. Fiad TM, Kirby JM, Cunningham SK, et al. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary- adrenal axis. Clin Endocrinol 1994;40:603-9. (Pubitemid 24194663)
16. Berneis K, Staub JJ, Gessler A, et al. Combined stimulation of adrenocorticotropin and compound-s by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab 2002;87:5470-5. (Pubitemid 36034346)
17. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2012. http://www. R-project.org/ (accessed Oct. 2012).
18. Fischli S, Jenni S, Allermann S, et al. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 2008;93:539-42. (Pubitemid 351240828)
19. Nasraallah MP, Arafah BM. The value of dehydroandrosterone sulphate measurements in the assessment of adrenal function. J Clin Endocrinol Metab 2003;88:5293-8. (Pubitemid 37452730)
20. Yamaji T, Ishibashi M, Takaku F, et al. Serum dehydroepiandrosterone sulfate concentrations in secondary adrenal insufficiency. J Clin Endocrinol Metab 1987;65:448-51. (Pubitemid 17135165)
21. Kannisto S, Korppi M, Remes K, et al. Serum dehydropepiandrosterone sulphate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled Steroids. J Clin Endocrinol Metab 2001;86:4908-12. (Pubitemid 33020540)
22. Sahiner UM, Cetinkaya S, Ozmen S, et al. Evaluation of adrenocortical function in 3-7 aged asthmatic children treated with moderate doses of fluticasone proprionate: reliability of dehydroepiandrosterone sulphate (DHEA-S) as a screening test. Allergol Immunopathol 2011;39:154-8.
23. Meikle AW, Kushnir MM, Rockwood AL, et al. Adrenal steroid concentration in children seven to seventeen years of age. J Pediatr Endocrinol Metab 2007;20:1281-91.
24. Auchus RJ. The physiology and biochemistry of adrenarche. In: Ghizzoni L, Cappa M, Chrousos G, Loche S, Maghnie M, eds. Pediatric adrenal disease. Endocrine development. Vol 20. Basel: Karger, 2011:20-7.
25. Havelock JC, Auchus RJ, Rainey WE. The rise in adrenal androgen biosynthesis: adrenarche. Semin Reprod Med 2004;22:337-47. (Pubitemid 40030083)
26. Clark DJ, Clark RA, Lipworth BJ. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax 1996;51:941-3. (Pubitemid 26289037)
27. Mormede P, Foury A, Barat P, et al. Molecular genetics of hypothalamic-pituitary-adrenal axis activity and function. Ann N Y Acad Sci 2011;1220:127-36.
28. De Rijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 2009;16:340-52.
29. Bertagna X, Coste J, Raux-Demay MC, et al. The combined corticotroph-releasing hormone/lysine vassopressin test discloses a corticotroph phenotype. J Clin Endocrinol Metab 1994;79:390-4. (Pubitemid 24256524)
30. Tsartsali L, Papadopoulos M, Lagona E, et al. Association of hypo-thalamic-pituitary-adrenal axis-related polymorphisms with stress in asthmatic children on inhaled corticosteroids. Neuroimmunomodulation 2012;19:88-95.